Development of a micro-scale method to assess the effect of corrosion on the mechanical properties of a biodegradable Fe-316L stent material.

Biodegradable stent Cold-gas dynamic spraying Corrosion Degradation Mechanical properties Micro-tensile

Journal

Journal of the mechanical behavior of biomedical materials
ISSN: 1878-0180
Titre abrégé: J Mech Behav Biomed Mater
Pays: Netherlands
ID NLM: 101322406

Informations de publication

Date de publication:
02 2021
Historique:
received: 22 05 2020
revised: 04 08 2020
accepted: 23 10 2020
pubmed: 9 11 2020
medline: 15 5 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

The application of biodegradable materials to stent design has the potential to transform coronary artery disease treatment. It is critical that biodegradable stents have sustained strength during degradation and vessel healing to prevent re-occlusion. Proper assessment of the impact of corrosion on the mechanical behaviour of potential biomaterials is important. Investigations within literature frequently implement simplified testing conditions to understand this behaviour and fail to consider size effects associated with strut thickness, or the increase in corrosion due to blood flow, both of which can impact material properties. A protocol was developed that utilizes micro-scale specimens, in conjunction with dynamic degradation, to assess the effect of corrosion on the mechanical properties of a novel Fe-316L material. Dynamic degradation led to increased specimen corrosion, resulting in a greater reduction in strength after 48 h of degradation in comparison to samples statically corroded. It was found that thicker micro-tensile samples (h > 200 μm) had a greater loss of strength in comparison to its thinner counterpart (h < 200 μm), due to increased corrosion of the thicker samples (203 MPa versus 260 MPa after 48 h, p = 0.0017). This investigation emphasizes the necessity of implementing physiologically relevant testing conditions, including dynamic corrosion and stent strut thickness, when evaluating potential biomaterials for biodegradable stent application.

Identifiants

pubmed: 33160911
pii: S1751-6161(20)30715-3
doi: 10.1016/j.jmbbm.2020.104173
pii:
doi:

Substances chimiques

Alloys 0
Biocompatible Materials 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104173

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Jennifer Frattolin (J)

Department of Mechanical Engineering, 817 Sherbrooke St. West, Room 270, McGill University, Montreal, Quebec, H3A 0C3, Canada.

Emanuele Cattarinuzzi (E)

Department of Chemistry, Materials and Chemical Engineering, Politecnico Milano, Piazza Leonardo da Vinci, 32, Milano, 20133, Italy.

Sriraman Rajagopalan (S)

Department of Mining and Materials Engineering, McGill University, 3610 University Street, Room 2140, Montreal, Quebec, H3A 0C5, Canada.

Dario Gastaldi (D)

Department of Chemistry, Materials and Chemical Engineering, Politecnico Milano, Piazza Leonardo da Vinci, 32, Milano, 20133, Italy.

Pasquale Vena (P)

Department of Chemistry, Materials and Chemical Engineering, Politecnico Milano, Piazza Leonardo da Vinci, 32, Milano, 20133, Italy.

Stephen Yue (S)

Department of Mining and Materials Engineering, McGill University, 3610 University Street, Room 2140, Montreal, Quebec, H3A 0C5, Canada.

Olivier F Bertrand (OF)

Department of Mechanical Engineering, 817 Sherbrooke St. West, Room 270, McGill University, Montreal, Quebec, H3A 0C3, Canada; Interventional Cardiology Laboratories, Quebec Heart and Lung Institute, Laval University, 2725 Chemin Sainte-Foy Quebec City, Quebec, G1V 4G5, Canada.

Rosaire Mongrain (R)

Department of Mechanical Engineering, 817 Sherbrooke St. West, Room 270, McGill University, Montreal, Quebec, H3A 0C3, Canada; Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, H1T 1C8, Canada. Electronic address: rosaire.mongrain@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH